Preventogen
Prevent-Plus, LLC is a biotech company based in St. Louis, Missouri, specializing in advanced wound care solutions. They manufacture and market FDA-cleared, non-antibiotic, microbicidal liquid polymers that create protective barriers over wounds, incisions, and skin to prevent infection and promote healing. Their innovative technology is backed by scientific and clinical data, and they aim to address global health challenges related to infections and wound care.
Industries
Nr. of Employees
small (1-50)
Products
Topical microbicidal liquid polymer (hospital-grade)
A non-antibiotic topical liquid polymer that kills microbes on contact and polymerizes into a flexible, breathable, biodegradable film to protect closed surgical incisions and minor wounds while supporting a healing environment.
Topical microbicidal liquid polymer (veterinary format)
Veterinary bottle format of the topical microbicidal liquid polymer indicated for protective covering of minor wounds, excisions and scrapes in animal care settings.
Topical microbicidal liquid polymer (hospital-grade)
A non-antibiotic topical liquid polymer that kills microbes on contact and polymerizes into a flexible, breathable, biodegradable film to protect closed surgical incisions and minor wounds while supporting a healing environment.
Topical microbicidal liquid polymer (veterinary format)
Veterinary bottle format of the topical microbicidal liquid polymer indicated for protective covering of minor wounds, excisions and scrapes in animal care settings.
Services
Clinical research and KOL development
Design and execution support for IRB-approved prospective and randomized clinical studies, clinical data generation, and engagement with key opinion leaders for study conduct and dissemination.
Strategic partnerships and commercialization support
Partnership development to expand technology applications, market entry support across hospital and retail channels, and collaboration opportunities for new medtech use cases.
Clinical research and KOL development
Design and execution support for IRB-approved prospective and randomized clinical studies, clinical data generation, and engagement with key opinion leaders for study conduct and dissemination.
Strategic partnerships and commercialization support
Partnership development to expand technology applications, market entry support across hospital and retail channels, and collaboration opportunities for new medtech use cases.
Expertise Areas
- Infection prevention
- Wound care and wound healing optimization
- Topical biomaterials development
- Antimicrobial efficacy testing (ASTM/GLP)
Key Technologies
- Elastomeric liquid polymer topical formulation
- Contact-kill microbicidal mechanism (cell lysis)
- CO2-infused polymer manufacturing to modulate pH
- E-beam sterilization (ISO 11137)